You are here: » Timelines » Cellink


» Timelines » Cellink


CELLINK is the first company in the world to commercialize a universal bioink for 3D Bioprinting of human tissues and organs. Along with producing bioinks, CELLINK also manufactures state of the art cost-effective 3D Bioprinters. As a global leader in 3D Bioprinting technology, CELLINK is working closely with hundreds of leading research institutions such as the FDA, Harvard and MIT.
Filtered by:
19 Dec

The coming of age of 3D bioprinting?

Though activities in 3D bioprinting have been growing in leaps and bounds since 2015, the activity we have seen in 2018 has been truly remarkable for this fledgling field. Finally, governments, academic institutions and companies alike are beginning to understand the value that 3D bioprinting can bring and are working hard together to bring disruptive change through building tissues from scratch.
24 Oct

Demonstration of CellInk's new BioX bioprinter

Dr Nadia Tsao, an IDTechEx Analyst met with a representative of CellInk to discuss their developments in the bioprinting sector, specifically their BioX bioprinter.
15 Oct


IDTechEx analyst Nadia Tsao spoke with Cellink CEO Erick Gatenholm and Cellink Head of Global Sales Johan Berthag at TERMIS WC 2018.
12 Oct

3D Printing in the Medical and Dental Industry 2019 - 2029

IDTechEx Report: Dr Bryony Core and Dr Nadia Tsao
10 Aug

Crocodile cartilage, human stem cells for 3D printed joint cartilage

A microbiologist in central Queensland is using 3D printing, human stem cells, and crocodile cartilage to find a new way to treat arthritis and joint injuries.
17 May


Update from the IDTechEx Show! Europe 2018
12 Apr

3D Bioprinting Of Human Soft Tissues

Cellink, Sweden
13 Mar

3D Bioprinting 2018 - 2028: Technologies, Markets, Forecasts

IDTechEx Report: Dr Nadia Tsao
10 Nov

Tissue Engineering 2018-2028: Technologies, Markets, Forecasts

IDTechEx Report: Dr Nadia Tsao
9 May

3D bioprinting - from science fiction to reality?

After over 15 years of research and development in academia and industry, several main applications of 3D bioprinting technology are ready to be realised.
20 Apr


IDTechEx analyst Nadia Tsao interviewed Cellink CEO Erik Gatenholm on April 20, 2017. The company focuses on developing a range of bioinks for 3D bioprinting, and also manufactures several 3D bioprinters.
Included are: